Friday, December 19, 2008
Liver function needs to be monitored in lung cancer patients taking Tarceva
TORONTO - The drug company Hoffman-La Roche is informing doctors about new safety information for one of its drugs used by lung cancer patients. It says liver function needs to be closely monitored by the doctor in patients who currently or recently have taken Tarceva....More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment